What's happening
This bill requires opioid prescription bottles in New York to have a warning label about addiction, depression, and overdose risks.
Why it matters
Raises patient awareness. at the critical moment of receiving opioids, potentially prompting more questions to healthcare providers about addiction, mental health, and safe usage, which could help prevent misuse.
Standardizes risk communication. by requiring all opioid prescriptions—regardless of prescriber or pharmacy—to include uniform, clear warnings about addiction, depression, and overdose, helping ensure consistent information across the state.
May impact prescribing and dispensing habits. as both pharmacists and physicians are reminded of the risks each time they dispense or prescribe opioids, possibly leading to more cautious practices or increased patient counseling.
Could support broader public health goals. by reinforcing the dangers of opioid use and encouraging safer consumption, contributing to ongoing efforts to combat the opioid crisis in New York.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Pharmacies dispensing opioids
They would need to affix an additional container label warning that the drug is highly addictive and may cause depression and overdose.
Patients receiving prescription opioids
Their medication containers would carry the warning and advise them to consult a pharmacist or physician before use.
Pharmacists and physicians
The required label would direct patients to them for consultation before using the opioid.
Headline styles
Warn Opioid Users on Bottles
Plain English, a few words. Used as the page title.
Sponsors
Assembly Member · Assembly District 26
No co-sponsors yet.
History
- Referred to health
- Referred to health
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Label Opioids With Warnings
In Senate Committee · Health · Sponsor Elijah Reichlin-Melnick
Full text
1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
6067
2021-2022 Regular Sessions
IN ASSEMBLY
March 8, 2021
Introduced by M. of A. BRAUNSTEIN -- read once and referred to the Committee on Health
AN ACT to amend the public health law, in relation to labeling prescription bottles of opioids
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Subdivision 2 of section 3333 of the public health law is amended by adding a new paragraph (d) to read as follows:
(d) In addition to the other requirements of this subdivision, where the controlled substance being dispensed is an opioid, there shall be affixed to the container a label upon which is indelibly typed, printed, or otherwise legibly written "Warning. This drug is highly addictive and may cause depression and overdose. Please consult your pharmacist or physician before using."
§ 2. This act shall take effect on the ninetieth day after it shall have become a law. Effective immediately, the addition, amendment and/or repeal of any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD08314-01-1
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.